MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Discriminating alpha-synuclein strains in Parkinson’s disease

I. Schniewind, S. Bräuer, E. Dinter, BH. Falkenburger (Dresden, Germany)

Meeting: 2024 International Congress

Abstract Number: 927

Keywords: Alpha-synuclein, Parkinson’s

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: To evaluate possible differences in the biological properties of alpha-synuclein fibrils derived from different patients with Parkinson’s disease.

Background: Parkinson’s disease (PD) is a clinically heterogeneous neurodegenerative disease characterized by Lewy bodies and neurites containing misfolded, aggregated alpha-synuclein (aSyn). Prion-like properties of aSyn aggregates contribute to the spread of neuropathology throughout the nervous system. aSyn seeds can be amplified from patient material such as cerebrospinal fluid, and our group has previously observed heterogeneity in the seeding behavior of aSyn seeds.

Method: In order to explore this heterogeneity further, we amplified aSyn seeds from cerebrospinal fluid samples of 20 patients with PD. The resulting fibrils were purified, adjusted in concentration, and transfected into aSyn-overexpressing HEK293T cells. The seeding of intracellular aSyn pathology was quantified using automated high-throughput microscopy and image analysis after staining for phosphorylated aSyn.

Results: Fibrils derived from distinct patients differ in their capacity to seed cellular aSyn pathology, and these seeding properties correlate with clinical parameters.

Conclusion: Our findings are consistent with the hypothesis that aSyn can form structurally distinct types of aggregates. They suggest that distinct strains may exist in patients with PD. This property could facilitate the stratification of patients with PD into prognostic subgroups and for disease-modifying clinical trials.

References: Previously presented at CURE-ND workshop, March 19th, 2024

To cite this abstract in AMA style:

I. Schniewind, S. Bräuer, E. Dinter, BH. Falkenburger. Discriminating alpha-synuclein strains in Parkinson’s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/discriminating-alpha-synuclein-strains-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/discriminating-alpha-synuclein-strains-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley